CTOs on the Move

Quidd

www.quidd.co

 
Quidd is the leading platform for buying, trading and using premium, rare digital goods.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Quidd raised $13M on 11/07/2017

Similar Companies

Bravura Networks

Bravura Networks is a San Diego, CA-based company in the Computers and Electronics sector.

ADVENIO STRATEGIES

ADVENIO STRATEGIES is a Arlington, VA-based company in the Computers and Electronics sector.

Velocity Technology

Velocity Technology Solutions is a leader in enterprise and business application services, fully- managed and protected within a virtual private, public or hybrid cloud. It is dedicated to lowering operational costs, providing industry-leading service levels and improving software performance while reducing the burden on IT staff and enabling deployment flexibility. Velocity provides virtual cloud solutions for enterprise applications with high levels of performance. Expertise managing software 24/7, combined with proprietary technology that enhances availability, security, and control, make Velocity the trusted partner for rapidly and securely deploying application investments into a secure and resilient virtual cloud. Velocity is headquartered in Charlotte with facilities in Minneapolis, Nashville, Denver, Tampa, India, Singapore, London (Canada), and Glasgow. Velocity is a portfolio company of Silver Lake Sumeru, a global leader in private equity investments in growth-oriented technology and technology-enabled companies.

Saama

Saama develops life science solutions that accelerate clinical and commercial development. Today, more than 50 biotech companies – including many of the top 20 pharmaceutical companies – use Saama`s award-winning Life Science Analytics Cloud (LSAC) platform to accelerate more than 1,500 studies, including the clinical trial led to the world`s first COVID-19 vaccine. LSAC`s rich applications facilitate unprecedented and authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Application (NDAs) more efficiently and bring treatments to patients sooner.